Lista de obras -

Ability To Serologically Confirm Recent Zika Virus Infection in Areas with Varying Past Incidence of Dengue Virus Infection in the United States and U.S. Territories in 2016.

artículo científico publicado en 2017

Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis

artículo científico publicado en 2013

An Assessment of the Cocooning Strategy for Preventing Infant Pertussis-United States, 2011.

artículo científico publicado en 2016

An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program

artículo científico publicado en 2005

Assessment of Tdap Vaccination Effectiveness in Adolescents in Integrated Health-Care Systems

artículo científico publicado en 2018

Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.

artículo científico publicado en 2012

Characteristics of Children Aged <18 Years with Zika Virus Disease Acquired Postnatally - U.S. States, January 2015-July 2016.

artículo científico publicado en 2016

Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT).

artículo científico publicado en 2018

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

artículo científico publicado en 2007

Detecting Local Zika Virus Transmission in the Continental United States: A Comparison of Surveillance Strategies.

artículo científico publicado en 2018

Early Impact of the US Tdap Vaccination Program on Pertussis Trends ⬇️

artículo científico publicado el 2 de enero de 2012

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial

artículo científico publicado en 2013

Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis

artículo científico publicado en 2010

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial

artículo científico

Epidemiologic and Laboratory Features of a Large Outbreak of Pertussis-Like Illnesses Associated With Cocirculating Bordetella holmesii and Bordetella pertussis—Ohio, 2010–2011 ⬇️

artículo científico publicado el 19 de octubre de 2012

Estimating the Effectiveness of Acellular Pertussis Vaccines ⬇️

artículo científico publicado el 7 de agosto de 2012

Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US.

artículo científico publicado en 2016

Evaluation of Level of Agreement in Bordetella Species Identification in Three U.S. Laboratories during a Period of Increased Pertussis

artículo científico publicado en 2015

Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in women

artículo científico publicado en 2008

Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human

artículo científico publicado en 2014

Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program

artículo científico publicado en 2006

Health-related quality of life in the Anthrax Vaccination Program for workers in the Laboratory Response Network.

artículo científico publicado en 2012

Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial.

artículo científico publicado en 2012

Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis

artículo científico publicado en 2016

Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation

artículo científico publicado en 2017

Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity

artículo científico publicado en 2012

Increased Risk for Meningococcal Disease among Men who have Sex with Men in the United States, 2012-2015.

artículo científico publicado en 2017

Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa

artículo científico publicado en 2010

Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.

artículo científico publicado en 2017

Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a University—Oregon, 2015

article published in 2016

Meningococcal Carriage Following a University Serogroup B Meningococcal Disease Outbreak and Vaccination Campaign with MenB-4C and MenB-FHbp - Oregon, 2015-2016.

artículo científico publicado en 2017

Meningococcal carriage among a university student population - United States, 2015.

artículo científico publicado en 2017

Meningococcal disease among men who have sex with men - United States, January 2012-June 2015.

artículo científico publicado en 2015

Molecular epidemiology of the pertussis epidemic in Washington State in 2012.

artículo científico publicado en 2014

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States

artículo científico publicado en 2006

Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage

artículo científico publicado en 2014

Pertussis Pseudo-outbreak Linked to Specimens Contaminated by Bordetella pertussis DNA From Clinic Surfaces ⬇️

artículo científico publicado el 16 de enero de 2012

Pertussis Vaccine Effectiveness in the Setting of Pertactin-Deficient Pertussis

artículo científico publicado en 2016

Population Diversity amongBordetella pertussisIsolates, United States, 1935–2009 ⬇️

artículo científico publicado el 1 de agosto de 2012

Population-Based Surveillance of Birth Defects Potentially Related to Zika Virus Infection - 15 States and U.S. Territories, 2016.

artículo científico publicado en 2018

Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy - U.S. Territories, January 1, 2016-April 25, 2017.

artículo científico

Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons

artículo científico

Principles of Epidemiology and Public Health

article

Qualitative Assessment of Pertussis Diagnostics in United States Laboratories ⬇️

artículo científico publicado el 1 de septiembre de 2013

Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons - Advisory Committee on Immunization Practices, 2016.

artículo científico publicado en 2016

Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination-United States, 2010-2012.

artículo científico publicado en 2017

Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine

scientific article published on 01 April 2007

Risk factors for Buruli ulcer disease (Mycobacterium ulcerans infection): Results from a case-control study in Ghana

artículo científico publicado en 2005

Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax.

artículo científico publicado en 2003

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data ⬇️

artículo científico publicado el 18 de julio de 2012

Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015.

artículo científico publicado en 2015

Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000-2007

artículo científico publicado en 2010

Severe Pertussis Infections in the United States, 2011-2015 ⬇️

artículo científico publicado en 2019

Sources of Infant Pertussis Infection in the United States

artículo científico publicado en 2015

Sustained Transmission of Pertussis in Vaccinated, 1-5-Year-Old Children in a Preschool, Florida, USA.

artículo científico publicado en 2016

Tdap vaccine effectiveness in adolescents during the 2012 Washington State pertussis epidemic

artículo científico publicado en 2015

Trends in Pertussis Diagnostic Testing in the United States, 1990 to 2012.

artículo científico publicado en 2015

Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States (Including U.S. Territories), July 2017.

artículo científico

Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Persons with Possible Zika Virus Exposure - United States, September 2016.

artículo científico publicado en 2016

Update: Noncongenital Zika Virus Disease Cases - 50 U.S. States and the District of Columbia, 2016.

artículo científico publicado en 2018

Uptake of pneumococcal conjugate vaccine among children in the 1998-2002 United States birth cohorts

artículo científico publicado en 2008

Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015.

artículo científico publicado en 2015

Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015.

artículo científico

Vaccine effectiveness of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during a pertussis outbreak in Maine

artículo científico publicado en 2016

Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016

artículo científico publicado en 2017

Waning immunity to pertussis following 5 doses of DTaP.

artículo científico publicado en 2013

West Nile Virus and Other Nationally Notifiable Arboviral Diseases - United States, 2017

scholarly article by Emily J Curren et al published 19 October 2018 in Morbidity and Mortality Weekly Report

Zika Virus Disease Cases - 50 States and the District of Columbia, January 1-July 31, 2016.

artículo científico publicado en 2016

Zika Virus IgM 25 Months after Symptom Onset, Miami-Dade County, Florida, USA.

artículo científico publicado en 2019

Zika Virus IgM Detection and Neutralizing Antibody Profiles 12-19 Months after Illness Onset

scholarly article by Isabel Griffin et al published February 2019 in Emerging Infectious Diseases

Zika Virus —10 Public Health Achievements in 2016 and Future Priorities

artículo científico publicado en 2016

Lista de obras de

Ability To Serologically Confirm Recent Zika Virus Infection in Areas with Varying Past Incidence of Dengue Virus Infection in the United States and U.S. Territories in 2016.

Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis

An Assessment of the Cocooning Strategy for Preventing Infant Pertussis-United States, 2011.

An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program

Assessment of Tdap Vaccination Effectiveness in Adolescents in Integrated Health-Care Systems

Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.

Characteristics of Children Aged <18 Years with Zika Virus Disease Acquired Postnatally - U.S. States, January 2015-July 2016.

Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT).

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

Detecting Local Zika Virus Transmission in the Continental United States: A Comparison of Surveillance Strategies.

Early Impact of the US Tdap Vaccination Program on Pertussis Trends ⬇️

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial

Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial

Epidemiologic and Laboratory Features of a Large Outbreak of Pertussis-Like Illnesses Associated With Cocirculating Bordetella holmesii and Bordetella pertussis—Ohio, 2010–2011 ⬇️

Estimating the Effectiveness of Acellular Pertussis Vaccines ⬇️

Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US.

Evaluation of Level of Agreement in Bordetella Species Identification in Three U.S. Laboratories during a Period of Increased Pertussis

Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in women

Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human

Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program

Health-related quality of life in the Anthrax Vaccination Program for workers in the Laboratory Response Network.

Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial.

Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis

Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation

Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity

Increased Risk for Meningococcal Disease among Men who have Sex with Men in the United States, 2012-2015.

Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa

Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.

Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a University—Oregon, 2015

Meningococcal Carriage Following a University Serogroup B Meningococcal Disease Outbreak and Vaccination Campaign with MenB-4C and MenB-FHbp - Oregon, 2015-2016.

Meningococcal carriage among a university student population - United States, 2015.

Meningococcal disease among men who have sex with men - United States, January 2012-June 2015.

Molecular epidemiology of the pertussis epidemic in Washington State in 2012.

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States

Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage

Pertussis Pseudo-outbreak Linked to Specimens Contaminated by Bordetella pertussis DNA From Clinic Surfaces ⬇️

Pertussis Vaccine Effectiveness in the Setting of Pertactin-Deficient Pertussis

Population Diversity amongBordetella pertussisIsolates, United States, 1935–2009 ⬇️

Population-Based Surveillance of Birth Defects Potentially Related to Zika Virus Infection - 15 States and U.S. Territories, 2016.

Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy - U.S. Territories, January 1, 2016-April 25, 2017.

Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons

Principles of Epidemiology and Public Health

Qualitative Assessment of Pertussis Diagnostics in United States Laboratories ⬇️

Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons - Advisory Committee on Immunization Practices, 2016.

Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination-United States, 2010-2012.

Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine

Risk factors for Buruli ulcer disease (Mycobacterium ulcerans infection): Results from a case-control study in Ghana

Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax.

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data ⬇️

Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015.

Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000-2007

Severe Pertussis Infections in the United States, 2011-2015 ⬇️

Sources of Infant Pertussis Infection in the United States

Sustained Transmission of Pertussis in Vaccinated, 1-5-Year-Old Children in a Preschool, Florida, USA.

Tdap vaccine effectiveness in adolescents during the 2012 Washington State pertussis epidemic

Trends in Pertussis Diagnostic Testing in the United States, 1990 to 2012.

Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States (Including U.S. Territories), July 2017.

Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Persons with Possible Zika Virus Exposure - United States, September 2016.

Update: Noncongenital Zika Virus Disease Cases - 50 U.S. States and the District of Columbia, 2016.

Uptake of pneumococcal conjugate vaccine among children in the 1998-2002 United States birth cohorts

Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015.

Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015.

Vaccine effectiveness of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during a pertussis outbreak in Maine

Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016

Waning immunity to pertussis following 5 doses of DTaP.

West Nile Virus and Other Nationally Notifiable Arboviral Diseases - United States, 2017

Zika Virus Disease Cases - 50 States and the District of Columbia, January 1-July 31, 2016.

Zika Virus IgM 25 Months after Symptom Onset, Miami-Dade County, Florida, USA.

Zika Virus IgM Detection and Neutralizing Antibody Profiles 12-19 Months after Illness Onset

Zika Virus —10 Public Health Achievements in 2016 and Future Priorities